Selected Review Articles

  1. Haruyama Y, Kataoka H:Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma. World J. Gastroenterol., 22, 275-283 (2016)
  2. Ishida Y, Takeshita M, Kataoka H: Functional foods effective for hepatitis C: Identification of oligomeric proanthocyanidin and its action mechanism. World J. Hepatol, 6 ,870-879 (2014)
  3. Kawaguchi M, Kataoka H: Mechanisms of Hepatocyte Growth Factor Activation in Cancer. Cancers, 6 (4), 1890-1904 (2014)
  4. Yotrita K, Ohno A, Kataoka H: Emerging histopathological prognostic biomarkers in hepatocellular carcinomas. Personalized Medicine Universe, 3:15?21 (2014)
  5. Kataoka H: Hepatocyte Growth Factor Activator. pp3016-3020. In: Rawlings ND & Salvesen GS (Eds.) Handbook of Proteolytic Enzymes, third edition. Oxford: Academic Press. (2013)
  6. Fukushima T: Chaptor 5; Alkylating Agents and Treatment of Gliomas. pp. 145-171 . In: Yildiz Dincer eds. Alkylating Agents as Environmental Carcinogen and Chemotherapy Agents. ISBN: 978-1-62618-487-9, Nova Science Publisher, Inc. (2013)
  7. Fukushima T and kataoka H: Chaptor 19; Insulin-Like Growth Factor Binding Protein-2: A Possible Regulator of Invasive Growth in Glioblastoma. In: Miklos Garami eds. Molecular Targets of CNS Tumors, ISBN: 978-953-307-736-9, InTech (2011)
  8. Kataoka H: Hepatocyte growth factor activator (HGFA): introduction. FEBS J 277:2207, 2010
  9. Kataoka H, Kawaguchi M: Hepatocyte growth factor activator (HGFA): pathophysiological functions in vivo. FEBS J 277:2230-2237, 2010
  10. Kataoka H. SPINT1 (serine peptidase inhibitor, Kunitz type 1). Atlas Genet Cytogenet Oncol Haematol. (2009)
  11. Fukushima, T., Takeshima, H., and Kataoka, H.: Anti-Glioma Therapy with Temozolomide and Status of the DNA-Repair Gene MGMT. Anticancer Res. 29:4845-4854 (2009)
  12. Fukushima, T. and Kataoka, H.: Roles of insulin-like growth factor binding protein-2 (IGFBP-2) in glioblastoma. Anticancer Res., 27:3685-3692 (2007)
  13. Yamada, G., Suzuki, K., Haraguchi, R., Miyagawa, S., Satoh, Y., Kamimura, M., Nakagata, N., Kataoka, H., Kuroiwa, A., and Chen, Y.: Molecular genetic cascades for external genitalia formation: An emerging organogenesis program. Dev. Dyn., 235:1738-1752 (2006)
  14. Itoh, H., Naganuma, S., Uchiyama, S., Nagaike, K., Tanaka, H., and Kataoka, H.: Activation of hepatocyte growth factor/scatter factor is required in colorectal carcinoma and injured intestinal mucosa. Recent Res. Devel. Biophys. Biochem., 4:1-16 (2004)
  15. Kataoka, H., Tanaka, H., Nagaike, K., and Uchiyama, S., Itoh, H.: Role of cancer cell-stroma interaction in invasive growth of cancer cells. Hum. Cell, 16:1-14 (2003)
  16. Kataoka, H., Miyata, S., Uchinokura, S., and Itoh, H.: Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor. Cancer Metast. Rev. 22:223-236 (2003)
  17. Itoh, H. and Kataoka, H.: Roles of hepatocyte growth factor activator (HGFA) and its inhibitor HAI-1 in the regeneration of injured gastrointestinal mucosa. J. Gastroenterol., 37:15-21 (2002)
  18. Kataoka, H., Itoh, H., and Koono, M.: Emerging multifunctional aspects of cellular serine proteinase inhibitors in tumor progression and tissue regeneration. Pathol. Int., 52:89-102 (2002)
  19. Kataoka, H., Akiyama, Y., Seguchi, T., Naganuma, S., and Itoh, H.: Immunohistochemical analysis if hepatocyte growth factor activator and its inhibitor HAI-1: Implication for regeneration of injured tissue and tumor progression. Recent Res. Devel. Histopathol. 1: 67-76 (2002)
  20. Kataoka, H., Itoh, H., Shimomura, T., Nuki, Y., Naganuma, S., and Miyazawa, K.: Regulation of hepatocyte growth factor (HGF) activation on cell surface: Insights into an emerging class of cell surface protease inhibitors. Int. Archiv Cell Biol., 1:1036-1042 (2001)
  21. Kataoka, H., Itoh, H., Hamasuna, R., Meng, J-Y., and Koono, M.: Pericellular activation of hepatocyte growth factor/scatter factor (HGF/SF) in colorectal carcinomas: Roles of HGF activator (HGFA) and HGFA inhibitor type 1 (HAI-1). Human Cell, 14:83-93 (2001)
  22. Uchino, H., Kataoka, H., Itoh, H., Sekiya, R., Onitsuka, T., and Koono, M.:Roles of intestinal trefoil factor (ITF) in human colorectal cancer: ITF suppresses the growth of colorectal carcinoma cells. Hum. Cell, 12:181-188 (1999)
  23. Nabeshima, K., Inoue, T., Shimao, Y., Kataoka, H., and Koono, M.: Cohort migration of carcinoma cells: Differentiated colorectal carcinoma cells move as coherent cell clusters or sheets. Histol. Histopathol. 14:1183-1197 (1999)
  24. Moriyama, T., Kataoka, H., Koono, M., and Wakisaka, S.: Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: Evidence for a role in progression of astrocytic tumors (Review). Int. J. Mol. Med., 3:531-536 (1999)
  25. Nabeshima, K., Inoue, T., Kataoka, H., and Koono, M.: Cohort migration of cancer cells. Connective tissue, 29:199-212 (1997)